Cambridge, United States
Gesund.ai, founded in 2021, is a standout in the burgeoning intersection of AI and healthcare. With its slogan, "highway to clinical-grade AI," this innovative company is carving out a niche as the world's first compliant AI factory aimed at expediting the journey of clinical-grade AI solutions to market.
Their platform audits and validates third-party medical AI solutions, ensuring safety, effectiveness, and equity, aligning with stringent regulatory requirements. This unique capability has earned Gesund.ai recognition as a CB Insights AI 100 entity, underscoring their leadership in the sector.
Headquartered in the United States, Gesund.ai is backed by notable investors such as Merck, McKesson, Northpond, and 500. Their recent investment comes from CancerX Moonshot, as of 01 February 2024, reflecting continued confidence from key stakeholders.
Operating at the confluence of AI, Information Technology, and Privacy and Security, Gesund.ai is setting the pace for AI-driven healthcare solutions.
